LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.890
+0.010 (0.53%)
Aug 23, 2024, 4:00 PM EDT - Market closed
LAVA Therapeutics Employees
LAVA Therapeutics had 37 employees as of December 31, 2023. The number of employees decreased by 32 or -46.38% compared to the previous year.
Employees
37
Change (1Y)
-32
Growth (1Y)
-46.38%
Revenue / Employee
$199,946
Profits / Employee
-$653,595
Market Cap
49.69M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 37 | -32 | -46.38% |
Dec 31, 2022 | 69 | 11 | 18.97% |
Dec 31, 2021 | 58 | 27 | 87.10% |
Dec 31, 2020 | 31 | - | - |
Related Stocks
Company Name | Employees |
---|---|
CareCloud | 3,600 |
Fortress Biotech | 186 |
Co-Diagnostics | 155 |
Barinthus Biotherapeutics | 130 |
Carisma Therapeutics | 107 |
Elicio Therapeutics | 32 |
FibroBiologics | 10 |
Lexaria Bioscience | 5 |
LVTX News
- 4 days ago - LAVA Reports Second Quarter 2024 Financial Results and Business Update - GlobeNewsWire
- 2 months ago - LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference - GlobeNewsWire
- 2 months ago - LAVA Announces Annual Meeting of Shareholders - GlobeNewsWire
- 3 months ago - LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 3 months ago - LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference - GlobeNewsWire
- 5 months ago - LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results - GlobeNewsWire
- 6 months ago - LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223) - GlobeNewsWire